文献速递脊柱外科创伤骨科

脊柱融合手术与局部抗生素应用:临床与前临床数据关键点的系统综述

Spinal Fusion Surgery and Local Antibiotic Administration: A Systematic Review on Key Points From Preclinical and Clinical Data.
PubMed 文献 · Spine (Phila Pa 1976) · 2020-01-01

本系统综述纳入36项临床研究、7项前临床研究和6项注册临床试验,聚焦脊柱融合术中局部抗生素给药预防手术部位感染(SSI)。结果表明局部万古霉素应用似乎可降低脊柱手术SSI发生率,但证据主要基于低级别、中/高偏倚风险的回顾性研究,尚无法得出明确结论。

要点

  • 局部万古霉素应用似乎可降低脊柱手术SSI发生率。
  • 该预防策略的证据主要基于回顾性研究,证据等级低。
  • 脊柱融合局部抗生素应用的多项关键问题仍待明确。

核心结论

  • 局部万古霉素应用似乎代表一种降低脊柱手术SSI发生率的策略。
  • 以局部万古霉素预防脊柱手术SSI主要基于证据等级低、偏倚风险中/重度的回顾性研究,无法得出明确结论。

研究设计与样本

  • 系统综述,遵循PRISMA声明,由两名独立研究者检索三个数据库及三个临床试验注册网站,纳入近10年前临床体内研究与临床报告。
  • 共纳入43篇文章:36项临床研究和7项前临床研究;另从临床注册网站选出6项临床试验。
  • 证据等级为4级。

主要发现

  • 无内置物时SSI发生率为0.7%至2.3%,使用内置物时高达6.7%。
  • 局部万古霉素应用似乎可降低脊柱手术SSI发生率。
  • 该预防策略的证据主要基于回顾性研究,证据等级低且偏倚风险中/重度。

局限性

  • 局部万古霉素预防脊柱手术SSI主要基于证据等级低的回顾性研究,偏倚风险中/重度,无法得出明确结论。
  • 关于脊柱融合中局部抗生素使用的多个关键问题仍有待明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Systematic review. OBJECTIVE: The present review of clinical and preclinical in vivo studies focused on the local antibiotic administration for surgical site infection (SSI) in spinal fusion procedures and identifying new approaches or research direction able to release antibiotics in the infected environment. SUMMARY OF BACKGROUND DATA: SSI is a severe complication of spinal fusion procedures that represents a challenging issue for orthopedic surgeons. SSIs can range from 0.7% to 2.3% without instrumentation up to 6.7% with the use of instrumentation with significant implications in health care costs and patient management. METHOD: A systematic search was carried out by two independent researchers according to the PRISMA statement in three databases (www.pubmed.com, www.scopus.com and www.webofknowledge.com) to identify preclinical in vivo and clinical reports in the last 10 years. Additionally, to evaluate ongoing clinical trials, three of the major clinical registry websites were also checked (www.clinicaltrials.gov, www.who.int/ictrp, https://www.clinicaltrialsregister.eu). RESULTS: After screening, a total of 43 articles were considered eligible for the review: 36 clinical studies and seven preclinical studies. In addition, six clinical trials were selected from the clinical registry websites. CONCLUSION: The results reported that the topical vancomycin application seem to represent a strategy to reduce SSI incidence in spine surgery. However, the use of local vancomycin as a preventive approach for SSIs in spine surgery is mostly based on retrospective studies with low levels of evidence and moderate/severe risk of bias that do not allow to draw a clear conclusion. This review also underlines that several key points concerning the local use of antibiotics in spinal fusion still remains to be defined to allow this field to make a leap forward that would lead to the identification of specific approaches to counteract the onset of SSIs. LEVEL OF EVIDENCE: 4.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Maria S, Deyanira C, Francesca S, et al. Spinal Fusion Surgery and Local Antibiotic Administration: A Systematic Review on Key Points From Preclinical and Clinical Data. Spine (Phila Pa 1976). 2020. PMID: 31568186. doi:10.1097/BRS.0000000000003255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。